11/21
08:05 am
hook
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at JMP Securities from $24.00 to $7.00. They now have a "market outperform" rating on the stock.
High
Report
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at JMP Securities from $24.00 to $7.00. They now have a "market outperform" rating on the stock.
11/15
11:23 am
hook
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Royal Bank of Canada from $50.00 to $48.00. They now have an "outperform" rating on the stock.
Medium
Report
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Royal Bank of Canada from $50.00 to $48.00. They now have an "outperform" rating on the stock.
11/15
05:31 am
hook
HOOKIPA Pharma GAAP EPS of -$1.10, revenue of $4.7M [Seeking Alpha]
Medium
Report
HOOKIPA Pharma GAAP EPS of -$1.10, revenue of $4.7M [Seeking Alpha]
11/14
04:17 pm
hook
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates [Yahoo! Finance]
Medium
Report
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates [Yahoo! Finance]
11/14
04:05 pm
hook
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
Medium
Report
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
11/11
04:05 pm
hook
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
Low
Report
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
10/31
09:20 am
hook
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 [Yahoo! Finance]
Low
Report
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 [Yahoo! Finance]
10/31
09:17 am
hook
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
Low
Report
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
10/30
07:30 am
hook
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
Low
Report
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
9/24
07:49 am
hook
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset [Yahoo! Finance]
Medium
Report
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset [Yahoo! Finance]
9/24
07:30 am
hook
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
Low
Report
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
9/17
08:00 am
hook
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm
Low
Report
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm
9/2
11:59 am
hook
Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet [Yahoo! Finance]
8/30
08:00 am
hook
HOOKIPA Pharma Announces Board of Directors Changes
Low
Report
HOOKIPA Pharma Announces Board of Directors Changes
8/28
09:09 am
hook
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
Medium
Report
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
8/28
08:57 am
hook
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference